Benzbromarone-Controlled, Double-Blind, Comparative Study of FYU-981 for Hyperuricemia With or Without Gout to Evaluate the Safety and Noninferiority of FYU-981 (Phase III Study)
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 11 Sep 2017
At a glance
- Drugs FYU-981 (Primary) ; Benzbromarone
- Indications Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Fuji Yakuhin
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2017 Status changed from not yet recruiting to recruiting.
- 06 Apr 2017 New trial record